Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Gut

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

IM erythropoietin + IV iron sucrose vs IV iron sucrose + IM placebo

Number of responders ‐ disease activity not stated (12 weeks) · IBD patients

IM erythropoietin + IV iron sucrose showed no clear difference in number of responders ‐ disease activity not stated (12 weeks) compared with IV iron sucrose + IM placebo (low certainty).

1 finding from 1 review

Interventions for treating iron deficiency anaemia in inflammatory bowel disease 2021 · Cochrane Headline outcomes only
RR 1.2 [0.9, 1.61]
1 study · 40 participants
Low

IM erythropoietin + IV iron sucrose vs IV iron sucrose + IM placebo

Serious adverse events ‐ disease activity not stated (12 weeks) · IBD patients

1 finding from 1 review

Interventions for treating iron deficiency anaemia in inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Very low